FENC

Fennec Pharmaceuticals (FENC)

About Fennec Pharmaceuticals (FENC)

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Details

Daily high
$6.96
Daily low
$6.61
Price at open
$6.82
52 Week High
$11.49
52 Week Low
$3.96
Market cap
183.2M
Dividend yield
0.00%
Volume
38
Avg. volume
58,991
P/E ratio
-66.80

Fennec Pharmaceuticals News

Details

Daily high
$6.96
Daily low
$6.61
Price at open
$6.82
52 Week High
$11.49
52 Week Low
$3.96
Market cap
183.2M
Dividend yield
0.00%
Volume
38
Avg. volume
58,991
P/E ratio
-66.80